Xcell Biosciences, Inc. — Form D

Xcell Biosciences, Inc. of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-02-23. The offering totals $11.9M, of which $11.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2017-02-23
• Form: D
• Accession: 0001140361-17-008805
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $11.9M
• Amount sold: $11.5M
• Remaining: $430K
• Investors: 33
• Date of first sale: 2017-01-24
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-281211

Issuer

• Name: Xcell Biosciences, Inc.
• CIK: 0001697666
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2012
• Address: 455 Mission Bay Blvd S, Suite 124, San Francisco, CA, 94158
• Phone: 415-937-0321

Officers, directors & promoters (10)

Other filings by this issuer (2)

More

• CIK 1697666 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search